Sector
PharmaceuticalsOpen
₹945.05Prev. Close
₹952.7Turnover(Lac.)
₹5,527.52Day's High
₹969Day's Low
₹940.252 Week's High
₹993.8552 Week's Low
₹412.1Book Value
₹383.19Face Value
₹10Mkt Cap (₹ Cr.)
8,790P/E
124.09EPS
7.67Divi. Yield
014 May 2024
12:00 AM
Board Meeting
Agenda : Audited Result
25 May 2023
12:00 AM
Dividend
Dividend Amount: 1.5
Record Date: 04 Aug, 2023
22 Jul 2023
12:00 AM
AGM
Announcement Date: 22 Jul, 2023
| Y/e 31 Mar( In .Cr) | Mar-2023 | Mar-2022 | Mar-2021 | Mar-2020 |
|---|---|---|---|---|
Equity Capital | 90.3 | 90.2 | 89.68 | 89.57 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 3,364.75 | 3,316.49 | 3,158.38 | 3,069.22 |
Net Worth | 3,455.05 | 3,406.69 | 3,248.06 | 3,158.79 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Revenue | 1,857.56 | 1,674.14 | 1,469.6 | 1,381.81 |
yoy growth (%) | 10.95 | 13.91 | 6.35 | -37.8 |
Raw materials | -988.87 | -887.97 | -781.25 | -734.46 |
As % of sales | 53.23 | 53.04 | 53.16 | 53.15 |
Employee costs | -272.72 | -221.76 | -224.53 | -228.47 |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Profit before tax | 111.63 | 151.85 | 193.51 | 197.8 |
Depreciation | -99.34 | -91.62 | -77.8 | -70 |
Tax paid | -33.39 | -40.15 | -7.68 | -30.71 |
Working capital | 95.65 | 115.9 | -16.3 | -240.87 |
Other operating items |
| Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 10.95 | 13.91 | 6.35 | -37.8 |
Op profit growth | -24.18 | 6.56 | 15.44 | -36.73 |
EBIT growth | -19.03 | -20.65 | 2.11 | -2.27 |
Net profit growth | -29.95 | -87.47 | 721.46 | -16.63 |
| Particulars (Rupees in Crores.) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 | Mar-2020 |
|---|---|---|---|---|---|
Gross Sales | 4,051.12 | 3,688.39 | 3,070.25 | 3,315.87 | 2,751.97 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 4,051.12 | 3,688.39 | 3,070.25 | 3,315.87 | 2,751.97 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 93.92 | 108.9 | 131.99 | 108.72 | 53.11 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceuticals Industries Ltd SUNPHARMA | 1,568.65 | 123.31 | 3,76,323.69 | 867.6 | 0.86 | 5,536.99 | 98.75 |
Divis Laboratories Ltd DIVISLAB | 4,519.8 | 76.17 | 1,19,994.45 | 531 | 0.66 | 2,259 | 507.93 |
Cipla Ltd CIPLA | 1,485.5 | 32.29 | 1,19,928.54 | 1,038.4 | 0.57 | 3,444.92 | 346.41 |
Zydus Lifesciences Ltd ZYDUSLIFE | 1,144.45 | 33.51 | 1,15,173.54 | 1,405.2 | 0.26 | 3,172.6 | 156.19 |
Dr Reddys Laboratories Ltd DRREDDY | 6,636 | 25.85 | 1,10,759.07 | 1,034.8 | 0.6 | 5,081.8 | 1,458.96 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairperson & M D
Arun Kumar
Non-Exec. & Independent Dir.
S Sridhar
Non-Exec. & Independent Dir.
Bharat D Shah
Company Sec. & Compli. Officer
Manjula Ramamurthy
Non-Exec. & Independent Dir.
Homi Rustam Khusrokhan
Executive Director (Finance)
Badree Komandur
Non-Exec. & Independent Dir.
Kausalya Santhanam
Tel: -
Website: -
Email: -
Tel: -
Website: -
Email: -
Reports by Strides Pharma Science Ltd
Summary
Strides Pharma Science Limited is a global pharmaceutical company headquartered in Bengaluru, India. The Company mainly operates in the regulated markets including key markets of US, Europe, Australia, South Africa. It has presence in the emerging markets largely in Africa where it has a branded business and is a pre qualified supplier to donor-funded programme though their institutional business. The Company is an integrated manufacturer and exporter of Finished Pharmaceutical Dosage forms for both branded and generic. It manufactures a very wide spectrum of ethical pharmaceutical products, OTC products and nutraceuticals. Their dosage forms range includes tablets, capsules, soft gelatin capsules, parenterals and semisolids. They undertake contract research and manufacturing of specialty chemicals. The Company has a global manufacturing footprint with 8 production units spread across three continents, of which, 6 manufacturing facilities cater to regulated markets and have key regulatory approvals including USFDA, UK MHRA, TGA, PMDA ANVISA, WHO. It own 2 dedicated production facilities for their emerging markets. It operates in more than 100 nations.Strides Pharma Science Limited was originally incorporated under the name Strides Arcolab Ltd in June 28th, 1990. In FY 2016, Shasun Pharmaceuticals Limited merged with Strides Arcolab forming a new identity Strides Shasun Limited, which became effective from 19 November, 2015 and name of the Company was changed to Strides Pharm
Read More
What is the Strides Pharma Science Ltd share price today?
The Strides Pharma Science Ltd shares price on N/A is Rs.₹954 today.
What is the Market Cap of Strides Pharma Science Ltd?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Strides Pharma Science Ltd is ₹8768.85 Cr. as of 22 Jul ‘24
What is the PE and PB ratio of Strides Pharma Science Ltd?
The PE and PB ratios of Strides Pharma Science Ltd is 124.09 and 2.46 as of 22 Jul ‘24
What is the 52 Week High and Low of Strides Pharma Science Ltd?
The 52-week high/low is the highest and lowest price at which a Strides Pharma Science Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Strides Pharma Science Ltd is ₹412.45 and ₹994.3 as of 22 Jul ‘24
What is the CAGR of Strides Pharma Science Ltd?
Strides Pharma Science Ltd's CAGR for 5 Years at 22.31%, 3 Years at 6.67%, 1 Year at 119.28%, 6 Month at 39.31%, 3 Month at 12.91% and 1 Month at -0.57%.
What is the shareholding pattern of Strides Pharma Science Ltd?
The shareholding pattern of Strides Pharma Science Ltd is as follows:
Promoters - 25.86 %
Institutions - 45.27 %
Public - 28.87 %
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2024, IIFL Securities Ltd. All Rights Reserved
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
